Xilio Therapeutics Inc. (XLO)

AI Score

Unlock

0.83

0.04 (4.55%)

At close: Apr 24, 2025, 3:59 PM

0.80

-4.04%

After-hours: Apr 24, 2025, 05:25 PM EDT

Xilio Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	55.29M	61.26M	74.95M	33.98M	44.7M	59.77M	75.38M	93.27M	120.39M	139.14M	159.41M	176.96M	198.05M	99.77M	120.3M	141.22M	19.24M	-48.84M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	97.69M
Long-Term Investments	n/a	n/a	1.77M	2.76M	1.59M	1.58M	1.57M	1.57M	1.56M	1.56M	1.55M	1.55M	1.55M	1.55M	1.55M	1.55M	n/a	n/a
Other Long-Term Assets	1.78M	1.77M	92K	121K	11K	169K	197K	3.94M	267K	301K	335K	359K	-3.15M	427K	436K	470K	2.05M	-48.84M
Receivables	n/a	n/a	n/a	30M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	4.94M	2.05M	3.06M	5.21M	3.42M	4.71M	3.04M	3.71M	4.11M	3.17M	3.6M	4.13M	4.46M	3.4M	2.35M	230K	n/a	n/a
Total Current Assets	60.23M	63.31M	78.01M	69.19M	48.13M	64.48M	78.42M	93.27M	124.5M	142.31M	163.01M	181.09M	202.52M	105.57M	124.59M	142.62M	20.59M	48.84M
Property-Plant & Equipment	9.06M	9.57M	10M	10.54M	11.2M	11.61M	12.16M	12.73M	12.84M	13.24M	13.23M	13.35M	13.6M	13.17M	13.45M	13.7M	13.68M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-5.09M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	10.84M	11.35M	11.87M	13.42M	12.8M	13.36M	13.93M	18.23M	14.67M	15.1M	15.12M	15.27M	15.54M	15.15M	15.44M	15.72M	15.73M	-48.84M
Total Assets	71.08M	74.66M	89.87M	82.61M	60.93M	77.84M	92.36M	111.5M	139.16M	157.41M	178.13M	196.35M	218.06M	120.72M	140.02M	158.34M	36.32M	n/a
Account Payables	2.57M	972K	1.26M	746K	1.05M	1.49M	945K	2.01M	3.13M	1.81M	1.41M	2.32M	3.14M	3.82M	8.41M	2.61M	5.44M	n/a
Deferred Revenue	13.52M	26.11M	26.52M	21.73M	n/a	9.4M	7.14M	n/a	n/a	n/a	12.09M	n/a	8.75M	8.19M	8.07M	1.00	13.73M	n/a
Short-Term Debt	n/a	n/a	1.12M	n/a	1.05M	1.01M	981K	6.67M	6.67M	5.89M	4.19M	2.5M	n/a	773K	4M	4.05M	2.33M	n/a
Other Current Liabilities	4.21M	3.36M	6.12M	6.67M	9.17M	9.36M	10.61M	82K	82K	4.53M	8.32M	5.09M	82K	4.4M	6.17M	8.71M	82K	n/a
Total Current Liabilities	27.26M	38.02M	38.64M	31.58M	15.96M	16.93M	16.29M	16.19M	21.12M	16.84M	17.77M	12.22M	12.78M	12.87M	21.3M	16.29M	22.16M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	8.14M	8.41M	n/a	1.55M	3.17M	4.78M	6.39M	8.01M	9.63M	19.9M	5.48M	6.45M	7.41M	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	-8.14M	-8.41M	7K	26K	45K	64K	82K	100K	118K	214.1M	224.03M	1.13M	79.13M	n/a
Total Long-Term Liabilities	26.22M	15.66M	17.82M	25.26M	8.14M	8.41M	8.69M	10.52M	12.4M	14.27M	16.14M	18.01M	19.85M	244.31M	240.03M	18.3M	97.45M	n/a
Total Liabilities	53.48M	53.68M	56.46M	56.84M	24.1M	25.34M	24.98M	26.71M	33.52M	31.12M	33.91M	30.23M	32.63M	257.18M	261.33M	34.59M	119.6M	n/a
Total Debt	8.14M	8.41M	8.68M	8.94M	12.55M	14.39M	16.81M	18.11M	19.94M	20.1M	20.25M	20.4M	20.54M	20.67M	20.75M	21.22M	21.22M	n/a
Common Stock	5K	4K	4K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	n/a	1K	1K	n/a	n/a
Retained Earnings	-383.75M	-370.66M	-356.64M	-342.71M	-325.51M	-307.86M	-291.11M	-271.75M	-249.11M	-226.64M	-206.85M	-182.24M	-160.89M	-141.19M	-124.93M	-101.75M	-85.09M	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	0.00	-0.00	n/a	n/a	n/a	0.00	n/a	n/a	n/a	-222.89M	-0.00	-0.00	-29.52M
Shareholders Equity	17.6M	20.97M	33.42M	25.77M	36.83M	52.5M	67.38M	84.79M	105.65M	126.3M	144.22M	166.12M	185.43M	-136.46M	-121.31M	123.75M	-83.29M	38.51M
Total Investments	n/a	n/a	1.77M	2.76M	1.59M	1.58M	1.57M	1.57M	1.56M	1.56M	1.55M	1.55M	1.55M	1.55M	1.55M	1.55M	n/a	97.69M